Sunshine Biopharma (NASDAQ:SBFM) Posts Earnings Results, Misses Expectations By $9.94 EPS

Sunshine Biopharma (NASDAQ:SBFM) announced its earnings results on Tuesday. The company reported ($0.94) earnings per share for the quarter, missing the consensus estimate of $9.00 by ($9.94), Zacks reports. The firm had revenue of $8.44 million during the quarter. Sunshine Biopharma had a negative net margin of 12.07% and a negative return on equity of 16.09%.

Sunshine Biopharma Stock Down 6.3 %

Shares of NASDAQ:SBFM traded down $0.18 during trading on Wednesday, reaching $2.68. The stock had a trading volume of 183,055 shares, compared to its average volume of 127,613. The stock has a market cap of $3.27 million, a P/E ratio of -0.01 and a beta of 1.38. The business has a fifty day moving average price of $2.96 and a 200-day moving average price of $1.64. Sunshine Biopharma has a fifty-two week low of $2.42 and a fifty-two week high of $637.20.

About Sunshine Biopharma

Sunshine Biopharma, Inc, a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products.